Read + Share
Day GS, Scarmeas N, Dubinsky R, Coerver K, et al. Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus: Report of the
AAN Guidelines Subcommittee. Neurology 2022 Feb 23. pii: WNL.0000000000200176.
PMID: 35197360
|
 |
|
Day GS, Scarmeas N, Dubinsky R, Coerver K, et al. Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus: Report of the
AAN Guidelines Subcommittee. Neurology 2022 Feb 23. pii: WNL.0000000000200176.
PMID: 35197360
|
|
|
|